Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Conduction System of the Heart01:19

Conduction System of the Heart

9.9K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
9.9K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

6.8K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
6.8K
Pulse rhythm01:30

Pulse rhythm

925
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
925
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

106
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
106
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Incremental Prognostic Value of Regurgitant Fraction in Patients with Ventricular Secondary Mitral Regurgitation.

Journal of clinical medicine·2026
Same author

European Society of Cardiology: cardiovascular disease statistics 2025.

European heart journal·2026
Same author

Predictors of stroke volume improvement with AV-optimized conduction system pacing in patients with AV dromotropathy.

ESC heart failure·2026
Same author

Three-dimensional ultrasound imaging: a review of the technology.

Physics in medicine and biology·2025
Same author

Modified Unipolar Return Pulsed Field Ablation in Ventricular Myocardium.

Circulation. Arrhythmia and electrophysiology·2025
Same author

Left bundle branch area pacing vs right ventricular pacing for atrioventricular block: the MELOS RELOADED study.

European heart journal·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Sep 10, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K

El ritmo del sistema de conducción frente al ritmo biventricular para la resincronización cardíaca: el estudio

David Žižek1,2, Tadej Žlahtič1,2, Miha Mrak1

  • 1Cardiology Department, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
|August 23, 2025
PubMed
Resumen

La estimulación del área de la rama izquierda (LBBAP) es tan efectiva como la estimulación biventricular (BiV) para la terapia de resincronización cardíaca (CRT). Este estudio encontró que el LBBAP no es inferior al ritmo BiV en la mejora de la función cardíaca y la remodelación.

Palabras clave:
Aceleración biventricularTerapia de resincronización cardíacaritmo del sistema de conducciónÁrea de ramas del haz izquierdoBloqueo de la rama del haz izquierdo

Más Videos Relacionados

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

903
Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

2.7K

Videos de Experimentos Relacionados

Last Updated: Sep 10, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

903
Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

2.7K

Área de la Ciencia:

  • Cardiología
  • Electrofisiología
  • El ritmo cardíaco

Sus antecedentes:

  • Existen estudios aleatorizados prospectivos limitados que comparan el ritmo LBBAP y BiV para la TCR.
  • Este estudio aborda la necesidad de datos comparativos en pacientes con TCR.

Objetivo del estudio:

  • Para comprobar si la LBBAP no es inferior a la estimulación BiV en pacientes con una indicación de Clase I para la TCR.
  • Evaluar la eficacia del LBBAP como una estrategia alternativa de TCR.

Principales métodos:

  • Estudio aleatorizado de CSP-SYNC iniciado por el investigador.
  • 62 pacientes fueron asignados al azar 1:1 a la estimulación LBBAP o BiV.
  • Endpoint primario: cambio en la fracción de eyección ventricular izquierda (LVEF) a los 6 meses.

Principales resultados:

  • La LBBAP demostró no ser inferior a la estimulación de BiV para la mejora de LVEF (14,0% frente a 8,5%, P< 0,001).
  • Ambos métodos de estimulación mostraron reducciones comparables en LVESV, mejoras en la prueba de caminata de 6 minutos y en la clase NYHA.
  • Se observaron tendencias similares en las tasas de remodelación de LV y hospitalización por insuficiencia cardíaca.

Conclusiones:

  • El LBBAP es una alternativa no inferior al estimulador BiV para la TCR en pacientes con indicación de Clase I.
  • LBBAP logra mejoras similares en LVEF, remodelación estructural y eléctrica en comparación con BiV pacing.